(Alliance News) - Aptamer Group PLC said on Tuesday that it has extended its contract with Unilever PLC for the development of novel Optimer binders for use in deodorant products.
The York, England-based biotechnology firm will partner with Unilever, the London-based consumer goods firm, to continue its work in testing Optimer binders as active ingredients in deodorants.
Aptamer said the use of active ingredients like Optimer binders in deodorant products is "highly novel" and "holds the potential for enhanced efficacy for customer products". Optimer binders target the C-S Lyase bacterial enzyme, which is critical in the generation of auxiliary odour.
The contract follows successful laboratory tests of the Optimer binders, allowing the partnership to progress to planned in-vivo studies before the end of 2024.
Aptamer Chief Executive Officer Arron Tolley said: "The continued advancement of our Optimer binders in collaboration with Unilever is a significant milestone for Aptamer Group. With efficacy testing on the horizon, we are optimistic about bringing these binders to market in the coming years and look forward to discussing commercial opportunities with Unilever upon successful trial outcomes."
Aptamer Group share prices were up 8.7% to 0.25 pence each in London on Tuesday morning.
By Emily Parsons, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2024 Alliance News Ltd. All Rights Reserved.


(Alliance News) - The FTSE 100 clung on to modest gains on Friday despite weak mining stocks, but Wall Street headed south after stronger-than-expecte...


* Barry Callebaut expects recurring EBIT to grow in medium term


(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced in the past week and not sep...


(Alliance News) - The FTSE 100 clung on to modest gains on Friday despite weak mining stocks, but Wall Street headed south after stronger-than-expecte...


* Barry Callebaut expects recurring EBIT to grow in medium term


(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced in the past week and not sep...


(Alliance News) - Unilever PLC on Thursday unveiled plans for a USD270 million US-based AI-powered global innovation centre which it said will help br...


NEW YORK, May 28 (Reuters) - Goldman Sachs' expects merger and acquisition volumes for the industry this year are on course to approach a 2021 reco...


NEW YORK, May 28 (Reuters) - Goldman Sachs' merger and acquisition volumes this year are on course to approach a 2021 record, with corporate activi...


ZURICH, May 26 (Reuters) - Terra Quantum has changed its partner for its planned $3.5 billion listing, the Swiss quantum technology company said on...


Oakley Capital Investments Ltd - closed-ended fund offering access to private equity investments of manager Oakley Capital Ltd - Invests up to GBP33 m...